Back to All Events
I will discuss the microbiome, what it is and what it does, and then discuss why the microbiome is of interest in relation to T1D. I will discuss our model of T1D in mice and how the findings might be relevant to both human illness, and how it may provide new leads to prevention and treatment.
Previous
Previous
July 29
Session 12: The Metabolic Syndrome in a Golgi Vesicle
Next
Next
July 30